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Delaney Still the Best
Protection
The December 1995 artide on pesticides in
food (EHP 103:1082) misstates the basic
issues around the Delaney Clause and misses
the point. While this federal regulation has
its limitations, such as it does not address all
food types such as raw fruits and vegetables
(and these limitations should be corrected),
contrary to what the article says, Delaney
offers the best possible protection ofpublic
health, induding children who are more sus-
ceptible and vulnerable, because it says that
no amount ofa carcinogen in food is accept-
able. There can be no better protection than
not allowing any carcinogen in food regard-
less ofwho eats it. All the alternatives to
Delaney incorporate some form of risk
assessment which will attempt to define
some level of"acceptable risk." These are the
approaches that will suffer many of the
problems described in the report, not
Delaney. Delaney needs fixing to expand its
reach. It should not be replaced by risk
assessment approaches thatwill be moresub-
jective, more vulnerable to assumptions and
uncertainties, and ultimately less protective
ofpublic health not only for children, but
foreveryone.
Stephen U. Lester
Citizens Clearinghouse for
HazardousWaste
Falls Church, Virginia
1-Hydroxypyrene as an
Indicator of Pyrene Exposure
The article by 0vreb0 et al. in the
September 1995 issueofEHP(103:838-843)
is a valuable contribution to environmental
health efforts in eastern Europe and will no
doubt serve as a benchmark in the future.
We do, however, have concerns about the
poor correlation between pyrene in air and
1-hydroxypyrene in urine found by 0vreb0
et al., which led them to conclude that
pyrene in air is not a strong predictor of 1-
hydroxypyrene. The basis for collection of
polycyclic aromatic hydrocarbons (PAHs)
using NIOSH method 5515 (1) assumes
PAHs up to fluoranthene are partially
retained on the filter substrate and all higher
PAHs are 100% retained. Hence, the
authors chose to collect only the particulate
fraction ofworkplace andambient air.
It is interesting to note the absence of
method validation data in NIOSH method
5515 but its indusion in NIOSH method
5506 (X. The difference in these two meth-
ods is solely the analytical method of analy-
sis: gas chromatography in 5515 and HPLC
in 5506. Inspection of measurement preci-
sion in NIOSH 5506 using spiked sampling
trains in a laboratory atmosphere indicates
PAHs ranging from naphthalene to fluoran-
thene exhibited significant volatilization and
PAHs from benz[a]anthracene to inde-
no[1,2,3-calpyrene showed no volatilization.
The data for pyrene were not determined.
Work by Kirton (3) has shown four-ring
PAHs incompletely retained on filters with
an approximate filter:sorbent ratio of 50:50
to 15:85 for pyrene and fluoranthene
depending on the filter particulate loading
(higher loadings mean more filter retention).
Sampling coal tar pitch volatiles in a
Soderbergpotroom ofan aluminum smelter,
Nyandco-workers (4) found48% ofpyrene
in backup XAD tubes. We fully support the
use ofPAH profiles as the first step in devel-
oping biological monitoring programs to
address PAH exposure, but consider the
effects ofincomplete collection ofpyrene in
the sampling stage to be a major deficiency
in the design of many published studies
(5-7). Correspondingly, incomplete atmos-
pheric sampling will lead to overestimates of
dermal absorption where this variable is cal-
culated using multiple regression analysis.
We would encourage (nay, insist) future
sampling in a way which presents loss or
nonrecoveryofanytarget compound.
The timing ofurine collection ofoccu-
pational samples by 0vreb0 et al. would not
allow one to properly determine the level of
1-hydroxypyrene arising from pyrene expo-
sure on the shift where personal measure-
ments were made. The half-life ofingested
pyrene was determined by Buckleyand Lioy
(8) to be4.4hr, withthe maximumelimina-
tion rate occurring at 6.3 hr. Accordingly,
samples should be collected 6-7 hr after the
work shift. The collection ofurine immedi-
ately after a single work shift does not allow
adequate time for elimination of pyrene
assimilated during that shift. This further
factorwould compound thepoorcorrelation
observed between pyrene in air and 1-
hydroxypyrene.
1-Hydroxypyrene is the major pyrene
metabolite in mammals; however, Grimmer
(9c detected another pyrene metabolite in
exposed workers: 1,2-dihydroxy-1,2-dihy-
dropyrene. This accounted for around one-
fifth to two-fifths ofthe pyrene metabolites
in a study ofcoke oven workers. Significant
interindividual differences in phenanthrene
metabolite profiles were also found. This
indicates a potential genetic difference in
PAH metabolite production, which may
affect the levels of 1-hydroxypyrene.
Knowledge ofthe effects ofP4501A1 induc-
tion and P450 isozymes on pyrene metabo-
lite ratios in chronically exposed humans
either through occupation or smoking is
needed to clarify the current role of 1-
hydroxypyrene as the sole indicator of
pyrene and, bydefault, PAH exposure.
Peter G. Knott
CapralAluminium Limited
Kurri Kurri, NewSouthWales, Australia
PeterJ. Kirton
BHP Environmental Health Laboratory
Port Kembla, NewSouthWales,Australia
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Response
In their letter, Knott and Kirton refer to the
incomplete collection of pyrene on filter
when collecting air samples in polycyclic
aromatic hydrocarbon (PAH)-polluted
atmospheres. We are aware ofthis phenome-
non, which is discussed in a recent book by
Bj0rseth and Becher (1). But the correlation
coefficient (X2) between pyrene in air and
urinary 1-hydroxypyrene is not dependent
on how complete the sampling ofpyrene is
as long as we sample a constant proportion
of the pyrene in air. We have studied the
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correlation between pyrene collected on fil-
ter and pyrene collected on XAD (4. On
average, we found 1.6 pg/m3pyrene on filter
and 1.9 pg/m3 on XAD; i.e., 46% on filter
and 54% on XAD. This is in good agree-
ment with Ny et al. (3). The correlation
between pyrene on filter and the sum of
pyrene on filter and pyrene on XAD was
0.69. Since this is less than 1, it is likely that
a better correlation between pyrene in air
and urinary 1-hydroxypyrene would have
been the result ofusing an XAD backup in
ourstudy.
The timing of urinary sampling is an
important issue. However, it is impossible to
select a perfect sampling time for biological
monitoring. Even ifyou sample for 8 hr and
start at a time point equal to the half-life of
1-hydroxypyrene after the start ofwork,
some of the collected urine will contain 1-
hydroxypyrene from the previous day's
exposure, and day-to-day variation may be
significant. Jongeneelen (4) has studied sam-
ples collected after and before shift and
found a correlation between pyrene in the
air and urinary 1-hydroxypyrene both when
collected after shift and before the shift the
next day. The American Conference of
Industrial Hygienists (ACGIH) has estab-
lished biological exposure indices (BEI) for
several organic compounds (but not pyrene)
and suggested sampling times. The ACGIH
suggested end ofshift and prior to next shift
as the time when sampling time is critical
(5). Compromises have to be made in prac-
tical biomonitoring, but for validation of
methods, 24-hr sampling of urine may be
important.
We agree that 1-hydroxypyrene is the
main metabolite and that other metabolites
are important, but urinary 1-hydroxypyrene
is a marker for PAH exposure and does not
represent the total exposure. A large propor-
tion of PAHs are excreted in feces. In a
recent study ofvoluntary ingestion and der-
mal application of pyrene, less than 4.5%
(ingestion) and 0.2% (dermal) ofthe dose
was recovered in a 48-hr collection period
(6). The study of the influence of genetic
factors and lifestyle factors is important in
validating biomarkers like urinary 1-
hydroxypyrene. We arecurrentlyconducting
such studies. But PAH uptake is also influ-
enced by particle size ofthe PAH. The new
filtercassettes called IOM (7) showthat con-
struction of cassette orifice can have a great
impact on the fraction samples and may be
more important than AD backup,which
mostly gives a constant loss that can be cor-
rectedfor.
There is still need for more validation
studies of the biomarker 1-hydroxypyrene.
To sum up, we would like tO cite from
implementation of the BET (5i): "Biological
monitoring should be considered comple-
mentary to air monitoring. Itshould be con-
ducted when it offers an advantage over the
useofairmonitoringalone."
Steinar 0vreb0
PerEinarFjeldstad
Elin HegiandKure
AageHaugen
National Institute ofOccupational Health
Oslo, Norway
EwaGrzybowska
MieczyslawChorazyInstitute ofOncology
Gliwice, Poland
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Radiation andChildhood Cancer
Ostensibly, the impetus for Wakeford's
review ofreported associations ofchildhood
cancers with radiation exposures (EHP
103:1018-1025) was to refuteourjudgment
that cancer risk coefficients for low-dose
exposures ofpopulations, as officially adopt-
ed by national and international radiation
commissions, have been substantially under-
estimated (EHP 102:656-667). We based
our judgment on documented inconsisten-
cies and omissions in theliterature, aswell as
on discrepancies between official predictions
and observed health effects among various
groups, induding nudear workers and resi-
dents of radioactively contaminated areas.
We reviewed a wide range ofstudies under
low-dose exposure conditions, especially
those that found radiogenic cancer risk coef-
ficients inconsistent with official estimates
forprotractedlow-dose exposures. Thesesig-
nificant discrepancies between observed and
expected values contradict the model
assumptions made when low-dose, low-rate
risks were extrapolated from primarily one-
flash, high-dose effects (1,2.
Wakeford ignores these inconsistencies
by neither refuting nor discussing them. His
substantive criticism ofour contribution is
limited to just two ofour reported finding,
which we can accept. Yet, this in no way
affects ourstated condusions:
1) We had overlooked a downward revi-
sion ofthe prenatal exposure risk of20 fatal
childhood cancers per 104 person-cGy (3) to
12.7 cancer deaths (and 17 nonfatal cancers)
per 104 person-cGy, as derived from the
Oxford Survey of Childhood Cancers
(OSCC) (4), generally recognized as the
most extensive database on childhood can-
cers. The main body ofWakeford's paper,
however, is apresentation ofalternative radi-
ogenic riskestimates, emphasizing those that
are closer to the generally accepted norm;
i.e., those derived from theA-bomb survivor
data. This brief communication is not the
appropriate place for adetailed evaluation of
Wakeford's selection ofdata. Yet, a crucial
omission from his review is the evidence we
referenced in our paper showing that, as a
consequence ofsignificant selection effects
among A-bomb survivors, prenatal exposure
risks as derived from A-bomb data are
intrinsically incompatible with those based
on X-ray exposures ofgeneral populations
(such as the OSCC). Recently released data
on early radiation injuries among the LSS
survivor cohort by the Radiation Effects
Research Foundation, Hiroshima, strongly
confirm Stewart's earlier condusions about
the effects ofselection (5). From now on,
evaluations of risk from prenatal exposures
to X-rays, low-dose gamma rays, or internal
radioisotopes will have to stand on their own
reliability in methodology, since agreement
or disagreement with the A-bomb data
appears tohavebecomeirrelevant.
2) Regarding the "Gardner hypothesis"
(postulating a genetic component for
leukemia in young people through precon-
ceptual parental exposure), we reviewed sev-
eral findings, supportive and unsupportive.
In view of the unknown contribution of
internal radioisotopes to the health hazards
in some ofthe conflictingfindings, aswell as
confounding dustering effects of leukemia
with infectious epidemics in rural areas (6),
we consider the discussion as undecided at
this time. In contrast to this more cautious
approach, Wakeford, without presenting a
plausible counter-hypothesis for either the
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